DVAX
Price
$10.58
Change
-$0.32 (-2.94%)
Updated
Jul 11 closing price
Capitalization
1.62B
19 days until earnings call
ELAN
Price
$14.90
Change
-$0.14 (-0.93%)
Updated
Jul 11 closing price
Capitalization
7.87B
26 days until earnings call
Interact to see
Advertisement

DVAX vs ELAN

Header iconDVAX vs ELAN Comparison
Open Charts DVAX vs ELANBanner chart's image
Dynavax Technologies
Price$10.58
Change-$0.32 (-2.94%)
Volume$3.84M
Capitalization1.62B
Elanco Animal Health
Price$14.90
Change-$0.14 (-0.93%)
Volume$3.84M
Capitalization7.87B
DVAX vs ELAN Comparison Chart in %
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. ELAN commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Buy and ELAN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (DVAX: $10.58 vs. ELAN: $14.90)
Brand notoriety: DVAX: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 183% vs. ELAN: 60%
Market capitalization -- DVAX: $1.62B vs. ELAN: $7.87B
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. ELAN’s [@Pharmaceuticals: Other] market capitalization is $7.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELAN is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 4 bearish.
  • ELAN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than DVAX.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а +3.02% price change this week, while ELAN (@Pharmaceuticals: Other) price change was +1.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +53.35%. For the same industry, the average monthly price growth was +4.99%, and the average quarterly price growth was +71.83%.

Reported Earning Dates

DVAX is expected to report earnings on Jul 31, 2025.

ELAN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+53.35% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than DVAX($1.62B). ELAN YTD gains are higher at: 23.039 vs. DVAX (-17.150). DVAX has higher annual earnings (EBITDA): 9.67M vs. ELAN (-224M). DVAX has more cash in the bank: 742M vs. ELAN (352M). DVAX has less debt than ELAN: DVAX (257M) vs ELAN (5.77B). ELAN has higher revenues than DVAX: ELAN (4.42B) vs DVAX (232M).
DVAXELANDVAX / ELAN
Capitalization1.62B7.87B21%
EBITDA9.67M-224M-4%
Gain YTD-17.15023.039-74%
P/E Ratio31.63N/A-
Revenue232M4.42B5%
Total Cash742M352M211%
Total Debt257M5.77B4%
FUNDAMENTALS RATINGS
DVAX vs ELAN: Fundamental Ratings
DVAX
ELAN
OUTLOOK RATING
1..100
1016
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9381
PRICE GROWTH RATING
1..100
6039
P/E GROWTH RATING
1..100
9893
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (69) in the Biotechnology industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that DVAX’s stock grew similarly to ELAN’s over the last 12 months.

DVAX's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that DVAX’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (81) in the Agricultural Commodities Or Milling industry is in the same range as DVAX (93) in the Biotechnology industry. This means that ELAN’s stock grew similarly to DVAX’s over the last 12 months.

ELAN's Price Growth Rating (39) in the Agricultural Commodities Or Milling industry is in the same range as DVAX (60) in the Biotechnology industry. This means that ELAN’s stock grew similarly to DVAX’s over the last 12 months.

ELAN's P/E Growth Rating (93) in the Agricultural Commodities Or Milling industry is in the same range as DVAX (98) in the Biotechnology industry. This means that ELAN’s stock grew similarly to DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXELAN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 20 days ago
80%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVADX62.18N/A
N/A
Franklin Small Cap Value Adv
OBIIX11.21N/A
N/A
Oberweis International Opps Instl
NRDGX24.08N/A
N/A
Neuberger Berman Dividend Growth R6
CWGCX70.57-0.30
-0.42%
American Funds Capital World Gr&Inc C
ABCRX22.83-0.13
-0.57%
American Beacon The London Co Inc Eq R6

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-2.94%
ACET - DVAX
39%
Loosely correlated
+1.31%
SNDL - DVAX
35%
Loosely correlated
-2.11%
ESPR - DVAX
34%
Loosely correlated
-4.03%
SUPN - DVAX
34%
Loosely correlated
-0.06%
ALKS - DVAX
34%
Loosely correlated
-0.59%
More

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with ZTS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.93%
ZTS - ELAN
48%
Loosely correlated
-2.42%
VTRS - ELAN
46%
Loosely correlated
-1.41%
PAHC - ELAN
40%
Loosely correlated
-1.09%
SNDL - ELAN
39%
Loosely correlated
-2.11%
TLRY - ELAN
36%
Loosely correlated
-8.88%
More